Phio Pharmaceuticals Corp. (PHIO)
1.05
+0.02
(+1.94%)
USD |
NASDAQ |
Dec 24, 12:59
1.03
-0.02
(-1.90%)
After-Hours: 13:59
Phio Pharmaceuticals SG&A Expense (TTM): 4.234M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Tharimmune, Inc. | 6.835M |
| NovaBay Pharmaceuticals, Inc. | 8.584M |
| Palatin Technologies, Inc. | 7.449M |
| Theriva Biologics, Inc. | 16.21M |
| Oragenics, Inc. | 6.832M |